Uptake of 18fluorodeoxyglucose in the cystic fibrosis lung: a measure of lung inflammation? Source: Eur Respir J 2003; 21: 848-854 Year: 2003
18F-fluorodeoxyglucose (18F-FDG) PET/CT assessment of aortic inflammation and calcification in COPD Source: International Congress 2017 – Imaging markers for COPD and asthma Year: 2017
In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma Source: Eur Respir J 2003; 21: 567-573 Year: 2003
Lung positron emission tomography with FDG in patients with haematological malignancies and acute respiratory failure Source: Eur Respir J 2016; 47: 324-327 Year: 2016
18F-FDG (fluorodeoxyglucose) uptake in focal organizing pneumonia mimicking bronchial carcinoma Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013
Increased FDG uptake on 18F-FDG PET/CT in residual lesions of tuberculosis Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019
The role of 18-FDG PET/CT in lung sarcoidosis Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017
Comparison of chest x-ray, thoracic computed tomography and 18F-FDG PET/CT for staging of sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015
Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer Source: Eur Respir J 2007; 29: 995-1002 Year: 2007
(18)F-FDG positron emission tomography/computed tomography and pulmonary function in sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013
18F-fluorodeoxyglucose (18FDG) PET pulmonary imaging in COPD Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment Year: 2015
Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis: an F-MISO PET/CT study Source: Eur Respir J, 58 (4) 2004584; 10.1183/13993003.04584-2020 Year: 2021
Positron emission tomography (PET) using 18 F-fluorodeoxyglucose (18 FDG) can detect radiographically ”occult“ lung cancer (ROLC) in the central airways Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001
Positron emission tomography with 18F-fluoro-deoxyglucose (FDG-PET) for evaluation of indeterminate adrenal mass in patients with lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 596s Year: 2002
Predictive value of 18F-FDG PET/CT for chemotherapy-related acute exacerbation of interstitial lung disease in lung cancer patients with interstitial lung disease Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019
Oxygen enhanced MRI biomarkers of lung function in interstitial lung disease Source: Virtual Congress 2020 – Quantitative imaging in diffuse lung disease Year: 2020
Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 227s Year: 2001
The role of positron emission tomography with 18F-2-fluoro-2-deoxy-D-glucose in respiratory oncology Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-34-0, page=245 Year: 2004
Influence of acute smoking on pulmonary inflammatory cell activity measured by positron emission tomography (PET) in asymptomatic cigarette smokers Source: Annual Congress 2005 - New modalities and application in lung and airway imaging Year: 2005
The role of FDG positron emission tomography in mediastinal lymph node evaluation for lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 125s Year: 2006